Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for ZVRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 -0.435M
March 31, 2026 -9.923M
December 31, 2025 -2.546M
September 30, 2025 -6.53M
June 30, 2025 -1.381M
March 31, 2025 -1.979M
December 31, 2024 -0.796M
September 30, 2024 -64.76M
June 30, 2024 -0.48M
March 31, 2024 -1.217M
December 31, 2023 -6.105M
September 30, 2023 -0.053M
June 30, 2023 -0.166M
March 31, 2023 3.447M
December 31, 2022 -0.176M
September 30, 2022 0.00
June 30, 2022 -0.216M
March 31, 2022 4.791M
December 31, 2021 2.853M
September 30, 2021 -0.86M
June 30, 2021 -4.173M
March 31, 2021 -73.77M
December 31, 2020 -0.013M
September 30, 2020 0.00
Date Value
June 30, 2020 0.097M
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 -23.50M
September 30, 2018 -0.836M
June 30, 2018 -4.06M
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 -0.004M
March 31, 2017 0.00
December 31, 2016 -0.713M
September 30, 2016 0.04M
June 30, 2016 0.473M
March 31, 2016 0.059M
December 31, 2015 -1.61M
September 30, 2015 0.539M
June 30, 2015 -59.24M
March 31, 2015 -4.042M
December 31, 2014 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Innoviva, Inc. 29.40M
Collegium Pharmaceutical, Inc. -0.481M
Johnson & Johnson -138.00M
Ligand Pharmaceuticals, Inc. -62.70M
Harrow, Inc. -0.811M